Clinical Trials Directory

Trials / Terminated

TerminatedNCT00965146

Scorpio® Cruciate Retaining (CR) Outcomes Study

An Open Label, Post-market, Non-randomized, Multi-center Study of the Outcomes of the Scorpio® Cruciate Retaining (CR) Total Knee System

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
215 (actual)
Sponsor
Stryker Orthopaedics · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the design and functional performance of the Scorpio® Cruciate Retaining (CR) Total Knee System.

Detailed description

The study design is a prospective, multi-center clinical trial. The Scorpio® Cruciate Retaining (CR) Total Knee System is to be implanted for evaluation in this study. This device system is commercially available and is intended for cemented use. The study group will consist of a maximum of 265 cases, requiring primary total knee replacement, and diagnosed with non-inflammatory arthritis. All subjects will be implanted with a femoral component, a tibial insert, a tibial tray and a resurfaced patella. Subjects receiving bilateral total knee replacements will represent two cases. Study participants will be recruited from 5 institutions. Subjects will be evaluated preoperatively and at follow-up intervals of 7 wks (± 2 wks), 3 months (± 3 weeks), 6 months (optional visit), 12 months (± 2 months) and annually thereafter (± 2 months). Each subject will be followed for 15 years post-implantation. The objectives of this study are to: 1. Evaluate the effect of system component design on functional performance. 2. Evaluate the effect of system component design by comparing postoperative functional and radiographic findings with preoperative. 3. Evaluate complications and the rates in which they occur.

Conditions

Interventions

TypeNameDescription
DEVICEScorpio® CR Total Knee SystemAll subjects will be implanted with a femoral component, a tibial insert, a tibial tray and a resurfaced patella.

Timeline

Start date
2001-06-01
Primary completion
2009-07-23
First posted
2009-08-25
Last updated
2017-11-17
Results posted
2013-02-15

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00965146. Inclusion in this directory is not an endorsement.